XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows provided by (used in) operating activities    
Net income (loss) $ 2,979,753 $ 1,631,592
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities    
Amortization, accretion and depreciation 251,608 (121,068)
Equity in undistributed (earnings) losses of other ventures 13,113 (2,566)
Net realized and unrealized (gains) losses on investments (552,405) 149,122
Change in:    
Premiums receivable (946,246) (789,338)
Prepaid reinsurance premiums (272,756) (7,504)
Reinsurance recoverable 605,649 457,666
Deferred acquisition costs and value of business acquired 32,337 (95,350)
Reserve for claims and claim expenses 734,325 62,592
Unearned premiums 905,014 663,389
Reinsurance balances payable (6,892) (604,675)
Other (357,594) 55,279
Net cash provided by (used in) operating activities 3,385,906 1,399,139
Cash flows provided by (used in) investing activities    
Proceeds from sales and maturities of fixed maturity investments trading 19,075,147 15,300,245
Purchases of fixed maturity investments trading (21,805,719) (17,053,131)
Proceeds from sales of equity investments 463 566,022
Purchases of equity investments (217) (1,706)
Proceeds from sales of short term investments 24,465,915 25,689,155
Purchases of short term investments (24,080,234) (27,466,343)
Proceeds from sales of other investments 784,065 334,214
Purchases of other investments (1,164,589) (860,164)
Purchases of investments in other ventures (56,674) (20,171)
Return of investment from investment in other ventures 1,301 2,752
Net cash provided by (used in) investing activities (2,780,542) (3,509,127)
Cash flows provided by (used in) financing activities    
Dividends paid – RenaissanceRe common shares (60,894) (55,239)
Dividends paid – preference shares (26,531) (26,531)
RenaissanceRe common share issuance, net of expenses 0 1,351,608
RenaissanceRe common share repurchases (215,305) 0
Issuance of debt, net of expenses 0 740,581
Repayment of Medici Revolving Credit Facility (100,000) (30,000)
Drawdown of Medici Revolving Credit Facility 75,000 0
Subscriptions of third-party redeemable noncontrolling interest shares 289,245 481,373
Redemptions of third-party redeemable noncontrolling interest shares (851,495) (337,652)
Taxes paid on withholding shares (21,515) (20,004)
Net cash provided by (used in) financing activities (911,495) 2,104,136
Effect of exchange rate changes on foreign currency cash 1,524 7,397
Net increase (decrease) in cash and cash equivalents (304,607) 1,545
Cash and cash equivalents, beginning of period 1,877,518 1,194,339
Cash and cash equivalents, end of period $ 1,572,911 $ 1,195,884